We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft Guidance Addresses Potency Assurance for Human Cellular and Gene Therapies
Draft Guidance Addresses Potency Assurance for Human Cellular and Gene Therapies
The FDA is seeking input on a new draft guidance intended to help manufacturers develop strategies for ensuring potency in human cellular or gene therapies (CGT).
